106 related articles for article (PubMed ID: 19900729)
21. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
23. Hypopituitarism and mortality in pituitary adenoma.
Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
[TBL] [Abstract][Full Text] [Related]
24. Radiation-induced brain disorders in patients with pituitary tumours.
Bhansali A; Banerjee AK; Chanda A; Singh P; Sharma SC; Mathuriya SN; Dash RJ
Australas Radiol; 2004 Sep; 48(3):339-46. PubMed ID: 15344984
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative radiotherapy for primary and locally recurrent soft tissue sarcoma: morbidity and long-term prognosis.
Lehnert T; Schwarzbach M; Willeke F; Treiber M; Hinz U; Wannenmacher MM; Herfarth C
Eur J Surg Oncol; 2000 Nov; 26 Suppl A():S21-4. PubMed ID: 11130875
[TBL] [Abstract][Full Text] [Related]
26. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
27. Recurrent pituitary adenomas after surgical resection: the role of radiation therapy.
Kovalic JJ; Grigsby PW; Fineberg BB
Radiology; 1990 Oct; 177(1):273-5. PubMed ID: 2399329
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
29. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
[TBL] [Abstract][Full Text] [Related]
31. Time without symptoms and toxicity (TWIST) analysis of adjuvant radiation therapy for endometrial cancer.
Jereczek-Fossa BA; Badzio A; Jassem J
Radiother Oncol; 2004 Aug; 72(2):175-81. PubMed ID: 15297136
[TBL] [Abstract][Full Text] [Related]
32. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients.
Colin P; Jovenin N; Delemer B; Caron J; Grulet H; Hecart AC; Lukas C; Bazin A; Bernard MH; Scherpereel B; Peruzzi P; Nakib I; Redon C; Rousseaux P
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):333-41. PubMed ID: 15890572
[TBL] [Abstract][Full Text] [Related]
33. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
Minniti G; Saran F; Traish D; Soomal R; Sardell S; Gonsalves A; Ashley S; Warrington J; Burke K; Mosleh-Shirazi A; Brada M
Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483
[TBL] [Abstract][Full Text] [Related]
34. [Postoperative radiotherapy in adenomas of the hypophysis].
Waugh E; Baeza MR; Tagle P; Arteaga E
Rev Med Chil; 1992 Feb; 120(2):147-52. PubMed ID: 1340551
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
36. [Hormonally inactive hypophyseal adenomas: the results and late sequelae after surgery and radiotherapy].
Grabenbauer GG; Fietkau R; Buchfelder M; Meyer M; Baumann J; Hensen J; Rummelt V; Fahlbusch R; Sauer R
Strahlenther Onkol; 1996 Apr; 172(4):193-7. PubMed ID: 8623081
[TBL] [Abstract][Full Text] [Related]
37. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.
Norberg L; Johansson R; Rasmuson T
Acta Oncol; 2010 Nov; 49(8):1276-82. PubMed ID: 20429723
[TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
[TBL] [Abstract][Full Text] [Related]
39. The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.
Sattler MG; van Beek AP; Wolffenbuttel BH; van den Berg G; Sluiter WJ; Langendijk JA; van den Bergh AC
Radiother Oncol; 2012 Jul; 104(1):125-30. PubMed ID: 22682541
[TBL] [Abstract][Full Text] [Related]
40. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.
Tsang RW; Brierley JD; Panzarella T; Gospodarowicz MK; Sutcliffe SB; Simpson WJ
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):557-65. PubMed ID: 7928486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
